FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

10 results

ambien
(zolpidem tartrate)
sanofi-aventis U.S. LLC
Usage: AMBIEN (zolpidem tartrate) is indicated for the short-term treatment of insomnia, specifically for difficulties with sleep initiation. It effectively reduces sleep latency for up to 35 days, as demonstrated in controlled clinical studies lasting 4–5 weeks.
ambien
(zolpidem tartrate)
sanofi-aventis U.S. LLC
Usage: AMBIEN CR (zolpidem tartrate extended-release tablets) is indicated for the short-term treatment of insomnia, particularly for difficulties with sleep onset and/or maintenance, as measured by wake time after sleep onset. Clinical trials supporting its efficacy lasted up to 24 weeks.
belsomra
(suvorexant)
Merck Sharp & Dohme LLC
Usage: BELSOMRA® (suvorexant) is indicated for treating insomnia, specifically for individuals who have trouble with sleep onset and/or sleep maintenance.
dayvigo
(lemborexant)
Eisai Inc.
Usage: DAYVIGO is indicated for the treatment of adult patients with insomnia, specifically for those experiencing difficulties with sleep onset and/or sleep maintenance.
doxepin
(Doxepin)
North Star Rx LLC
Usage: Doxepin tablets are indicated for treating insomnia, specifically for individuals experiencing difficulty with sleep maintenance, based on clinical trials lasting up to 3 months.
eszopiclone
(Eszopiclone)
Teva Pharmaceuticals USA, Inc.
Usage: Eszopiclone tablets are indicated for the treatment of insomnia, as they have been shown to decrease sleep latency and improve sleep maintenance in clinical studies lasting up to 6 months.
halcion
(triazolam)
Pharmacia & Upjohn Company LLC
Usage: Halcion is indicated for the short-term treatment of insomnia in adults, typically for a duration of 7 to 10 days.
silenor
(doxepin hydrochloride)
Currax Pharmaceuticals LLC
Usage: SILENOR is indicated for the treatment of insomnia characterized by difficulty maintaining sleep, with clinical trials supporting its efficacy for up to 3 months.
triazolam
(triazolam)
Greenstone LLC
Usage: Triazolam is indicated for the short-term treatment of insomnia in adults, typically for a duration of 7 to 10 days.
zolpidem tartrate
(Zolpidem Tartrate)
Lupin Pharmaceuticals, Inc.
Usage: Zolpidem tartrate extended-release tablets are indicated for the short-term treatment of insomnia, specifically for difficulties with sleep onset and/or maintenance, as measured by wake time after sleep onset.

Medications for Primary Insomnia

ambien

ambien

belsomra

dayvigo

doxepin

eszopiclone

halcion

silenor

triazolam

zolpidem tartrate